Eli Lilly Long-Term Investments 2010-2024 | LLY

Eli Lilly long-term investments for the quarter ending December 31, 2024 were $3.216B, a 5.36% increase year-over-year.

  • Eli Lilly long-term investments for 2024 were $3.216B, a 5.36% increase from 2023.
  • Eli Lilly long-term investments for 2023 were $3.052B, a 5.18% increase from 2022.
  • Eli Lilly long-term investments for 2022 were $2.902B, a 9.67% decline from 2021.

Eli Lilly Long-Term Investments 2010-2024 | LLY

  • Eli Lilly long-term investments for 2024 were $3.216B, a 5.36% increase from 2023.
  • Eli Lilly long-term investments for 2023 were $3.052B, a 5.18% increase from 2022.
  • Eli Lilly long-term investments for 2022 were $2.902B, a 9.67% decline from 2021.
Related Stocks
Company NameMarket
Cap
Johnson & Johnson (JNJ)$384.4B
Novo Nordisk (NVO)$375.8B
AbbVie (ABBV)$354.6B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Novartis AG (NVS)$219.3B
Pfizer (PFE)$146.8B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B